| Breakdown | TTM | Mar 2024 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.74M | 55.65M | 48.09M | 32.86M | 52.55M | 46.63M |
| Gross Profit | 24.98M | 24.91M | 17.91M | 13.51M | 25.01M | 46.63M |
| EBITDA | 3.75M | 3.05M | -1.83M | -40.00K | 10.50M | 11.98M |
| Net Income | 1.45M | 765.00K | -3.55M | -5.52M | 6.51M | 7.03M |
Balance Sheet | ||||||
| Total Assets | 88.40M | 77.25M | 78.30M | 51.96M | 66.62M | 58.79M |
| Cash, Cash Equivalents and Short-Term Investments | 24.65M | 25.41M | 24.93M | 9.63M | 25.28M | 20.43M |
| Total Debt | 13.33M | 9.55M | 12.29M | 13.26M | 14.23M | 15.32M |
| Total Liabilities | 49.24M | 37.41M | 38.68M | 25.99M | 33.55M | 30.49M |
| Stockholders Equity | 39.16M | 39.84M | 39.62M | 25.97M | 33.06M | 28.30M |
Cash Flow | ||||||
| Free Cash Flow | 10.12M | 6.71M | 1.38M | -11.11M | 7.90M | 15.16M |
| Operating Cash Flow | 10.17M | 6.92M | 1.66M | -10.34M | 8.53M | 17.21M |
| Investing Cash Flow | -328.00K | 293.00K | 11.59M | -1.92M | 879.00K | -2.02M |
| Financing Cash Flow | -6.68M | -6.73M | -1.89M | -3.39M | -4.47M | 52.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £8.16M | -9.72 | 12.70% | 2.64% | 6.86% | 64.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
61 Neutral | £3.13M | ― | 66.17% | 26.13% | ― | ― | |
60 Neutral | £32.75M | 13.98 | 3.68% | 7.96% | -9.55% | ― | |
58 Neutral | £121.91M | 3.75 | 4.98% | ― | 15.42% | ― | |
50 Neutral | £2.09M | -2.62 | -10.57% | ― | -57.15% | -77.78% | |
48 Neutral | £8.73M | -0.20 | ― | ― | ― | ― |